High-Dose Sirolimus and Immune-Selective Pentostatin plus Cyclophosphamide Conditioning Yields Stable Mixed Chimerism and Insufficient Graft-versus-Tumor Responses-Reference-Cited by-同舟云学术

High-Dose Sirolimus and Immune-Selective Pentostatin plus Cyclophosphamide Conditioning Yields Stable Mixed Chimerism and Insufficient Graft-versus-Tumor Responses

Published:2015-06-12 Issue:19 Volume:21 Page:4312-4320
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Mossoba Miriam E.,Halverson David C.,Kurlander Roger,Schuver Bazetta Blacklock,Carpenter Ashley,Hansen Brenna,Steinberg Seth M.,Ali Syed Abbas,Tageja Nishant,Hakim Frances T.,Gea-Banacloche Juan,Sportes Claude,Hardy Nancy M.,Hickstein Dennis D.,Pavletic Steven Z.,Khuu Hanh,Sabatini Marianna,Stroncek David,Levine Bruce L.,June Carl H.,Mariotti Jacopo,Rixe Olivier,Fojo Antonio Tito,Bishop Michael R.,Gress Ronald E.,Fowler Daniel H.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drugs targeting adenosine signaling pathways: A current view;Biomedicine & Pharmacotherapy;2023-09

2. Haploidentical stem cell transplantation for patients with sickle cell disease: current status;Transfusion and Apheresis Science;2022-10

3. Beyond fludarabine: pentostatin plus cyclophosphamide are a well-tolerated alternative in reduced intensity conditioning;Bone Marrow Transplantation;2022-09-17

4. Prospective Study of a Novel, Radiation-Free, Reduced-Intensity Bone Marrow Transplantation Platform for Primary Immunodeficiency Diseases;Biology of Blood and Marrow Transplantation;2020-01

5. Cytomegalovirus Infection Incidence and Risk Factors Across Diverse Hematopoietic Cell Transplantation Platforms Using a Standardized Monitoring and Treatment Approach: A Comprehensive Evaluation from a Single Institution;Biology of Blood and Marrow Transplantation;2019-03